The partial C. reinhardtii PEPC1 corresponds to a 639-bp fragment of the pepc2 gene (GenBank accession: not explicitly provided in sources), cloned into prokaryotic expression vectors . This fragment encodes a bacterial-type PEPC (BTPC) domain, distinct from plant-type PEPC (PTPC), and shares ~65% sequence identity with E. coli PEPC . Key features include:
Catalytic Domain: Retains conserved residues for PEP binding and β-carboxylation.
Regulatory Domain: Lacks full-length eukaryotic regulatory motifs, rendering it insensitive to malate inhibition .
Expression System: Successfully expressed in E. coli BL21(DE3), yielding soluble protein with altered kinetic properties .
Recombinant partial PEPC1 acts as a metabolic pivot, regulating carbon partitioning between protein and lipid biosynthesis. Experimental findings include:
| Parameter | Wild Type | Reverse Mutant (PEPC↓) | Forward Mutant (PEPC↑) |
|---|---|---|---|
| PEPC Activity (U/mg) | 1.7 | 0.9 (-47%) | 2.4 (+47%) |
| Soluble Protein (mg/g) | 186 | 119 (-36%) | 230 (+24%) |
| Total Lipid (mg/g) | 56 | 71 (+28%) | 44 (-21%) |
| Growth Rate (% of WT) | 100 | 95 | 114 |
Downregulation (reverse mutant): Enhanced lipid accumulation (+28%) at the expense of soluble protein, suggesting redirected carbon flux toward acetyl-CoA for fatty acid synthesis .
Upregulation (forward mutant): Increased amino acid biosynthesis (+24% soluble protein) and suppressed lipid synthesis .
| Primer | Sequence (5’→3’) | Purpose |
|---|---|---|
| P1 | CGATGCTCGGTAGCCTGCTTGACG (ATG) | Forward, start codon |
| P2 | TAGGGATCCACAACGACTGCTCCACA (BamHI) | Reverse, cloning site |
The 639-bp fragment was ligated into pET-28a(+) vectors under T7 promoter control .
RT-qPCR confirmed pepc expression levels: 362% in forward mutants vs. 29% in reverse mutants relative to wild-type E. coli .
Metabolic Engineering: Partial PEPC1 expression in E. coli increased lipid yields by 28%, demonstrating potential for biodiesel production .
Biochemical Studies: The truncated enzyme’s insensitivity to malate simplifies in vitro assays for substrate affinity analysis .
Phosphoenolpyruvate carboxylase 1 (Ppc1) in C. reinhardtii is a distinct molecular form of the PEPC enzyme that catalyzes the irreversible β-carboxylation of phosphoenolpyruvate (PEP) to form oxaloacetate and inorganic phosphate. Unlike its vascular plant counterparts, C. reinhardtii Ppc1 lacks the regulatory N-terminal seryl-phosphorylation domain typical of plant PEPC enzymes. The CrPpc1 gene encodes a protein with a predicted molecular mass of approximately 108.9 kDa, which is significantly smaller than the CrPpc2 isoform (~131.2 kDa) . The Ppc1 transcript specifically encodes the p102 catalytic subunits that are common components in both Class-1 (homotetrameric) and Class-2 (heteromeric) enzyme forms in C. reinhardtii . This unique structural characteristic distinguishes algal PEPC from its plant and prokaryotic counterparts, suggesting evolutionary adaptations specific to microalgal metabolism.
C. reinhardtii Ppc1 exhibits several key differences from plant and bacterial PEPC enzymes. First, while plant PEPCs typically contain an N-terminal phosphorylation domain that regulates enzyme activity through reversible phosphorylation, C. reinhardtii Ppc1 lacks this regulatory domain entirely . Second, C. reinhardtii possesses two distinct PEPC isoforms (Ppc1 and Ppc2) that differ in their molecular mass, C-terminal tetrapeptide sequences, and immunoreactivity patterns . The Ppc1 enzyme specifically functions within both Class-1 and Class-2 enzyme complexes, whereas bacterial PEPCs typically exist as simple homotetramers. Third, algal PEPC exhibits unique regulatory responses to environmental factors such as CO2 and nitrogen availability, with transcript levels being coordinately regulated by changes in these parameters . These distinctive features suggest that C. reinhardtii PEPC has evolved specialized functions in carbon and nitrogen metabolism that differ from the roles played by PEPC in higher plants and prokaryotes.
Ppc1 in C. reinhardtii serves multiple metabolic functions, primarily centered around carbon fixation and nitrogen assimilation. As a key anaplerotic enzyme, Ppc1 replenishes tricarboxylic acid (TCA) cycle intermediates by catalyzing the formation of oxaloacetate from PEP. This function is particularly important during conditions of limited CO2 availability or elevated nitrogen requirements. The coordinated regulation of CrPpc1/2 transcript levels with changes in CO2 and NH4+ concentrations suggests a direct role in balancing carbon and nitrogen metabolism . Specifically, Ppc1 expression patterns mirror the response of cytoplasmic glutamine synthetase (Gs1) transcript abundance to changes in inorganic nitrogen at 5% CO2, indicating an integrated role in nitrogen assimilation pathways . These metabolic functions highlight Ppc1's importance in maintaining cellular homeostasis under varying environmental conditions and explain why this enzyme is a target for metabolic engineering efforts aimed at enhancing biomass production or biofuel synthesis in microalgae.
The expression of Ppc1 in C. reinhardtii is subject to sophisticated regulatory mechanisms that respond to environmental cues, particularly carbon and nitrogen availability. Studies have demonstrated that the steady-state transcript levels of both CrPpc1 and CrPpc2 are coordinately up- or down-regulated by changes in CO2 or NH4+ concentrations during growth . This regulation occurs at the transcriptional level, where promoter elements responsive to carbon and nitrogen status modulate gene expression. The pattern of Ppc1 transcript abundance generally mirrors the response of cytoplasmic glutamine synthetase (Gs1) transcript to changes in inorganic nitrogen concentration, especially under elevated CO2 conditions (5%) . This coordinated regulation suggests that transcription factors involved in carbon and nitrogen sensing pathways simultaneously target multiple genes in related metabolic processes. Additionally, post-transcriptional mechanisms likely play roles in fine-tuning Ppc1 levels in response to metabolic demands, although these mechanisms are less well characterized than the transcriptional controls governing initial gene expression.
Several environmental factors significantly impact recombinant Ppc1 expression in C. reinhardtii, with temperature, light conditions, and growth medium composition being the most critical variables. Temperature exerts a profound effect on both cell growth and recombinant protein accumulation, with studies on other recombinant proteins in C. reinhardtii suggesting that 30°C under mixotrophic conditions provides optimal expression levels . Light intensity and photoperiod also influence recombinant protein production, with moderate light intensities generally yielding better results than high intensity light, which can cause photooxidative stress. The choice between phototrophic, heterotrophic, or mixotrophic growth conditions significantly affects recombinant protein yields, with mixotrophic cultivation often providing the best balance between growth rate and protein expression . Additionally, media composition, particularly carbon source concentration and nitrogen availability, must be optimized for Ppc1 expression. The following table summarizes the key environmental factors affecting recombinant protein expression in C. reinhardtii:
| Environmental Factor | Optimal Condition | Effect on Expression |
|---|---|---|
| Temperature | 30°C | Enhances protein folding and accumulation |
| Light Regime | Moderate intensity, 16:8 photoperiod | Balances photosynthetic activity and stress |
| Growth Mode | Mixotrophic | Combines benefits of photosynthesis and external carbon |
| Medium | TAP with optimized C:N ratio | Provides balanced nutrients for growth and expression |
| CO2 Concentration | 2-5% | Enhances photosynthetic efficiency |
Carbon and nitrogen availability serve as key regulatory signals for both Ppc1 expression and enzymatic activity in C. reinhardtii. Transcript analysis has revealed that Ppc1 expression is coordinately regulated by changes in CO2 and NH4+ concentrations . Under limited CO2 conditions, Ppc1 expression is typically upregulated to enhance anaplerotic carbon fixation, providing oxaloacetate for the TCA cycle. Conversely, when CO2 is abundant, Ppc1 expression may be downregulated as direct carbon fixation through the Calvin cycle becomes predominant. Nitrogen availability similarly influences Ppc1 expression patterns, with transcript levels often mirroring those of nitrogen assimilation enzymes like glutamine synthetase . Beyond transcriptional regulation, enzyme activity is also modulated by metabolite levels, with certain TCA cycle intermediates and amino acids serving as allosteric regulators. This metabolic regulation allows for rapid adjustments to enzyme activity in response to changing intracellular conditions. Understanding these regulatory mechanisms is essential for designing expression systems that maintain consistent recombinant Ppc1 production under various cultivation conditions.
For optimal recombinant Ppc1 production in C. reinhardtii, chloroplast expression vectors have proven most effective due to their high protein yield capabilities and stable integration into the chloroplast genome. The pASapI vector system represents a particularly valuable tool, as it utilizes endogenous promoters and regulatory elements that drive high-level expression . For Ppc1 expression, vectors incorporating the atpA promoter/5′UTR element coupled with the rbcL 3′UTR have demonstrated strong expression capabilities similar to those used for other recombinant proteins . Codon optimization is essential when designing the Ppc1 expression cassette, as the chloroplast genome has distinct codon usage preferences compared to the nuclear genome. Additionally, incorporating a C-terminal epitope tag (such as HA-tag) facilitates protein detection and purification without significantly affecting enzyme activity . For enhanced expression, dual-promoter systems that combine the strengths of different endogenous promoters (e.g., atpA and psaA) can drive both the target gene and accessory factors such as chaperones that aid in proper protein folding . Selection markers like spectinomycin resistance enable efficient screening of transformed lines, while the incorporation of homologous flanking sequences ensures stable integration into the chloroplast genome.
Codon optimization represents a critical strategy for enhancing recombinant Ppc1 expression in C. reinhardtii. The chloroplast genome of C. reinhardtii exhibits distinct codon usage preferences that differ significantly from those of the nuclear genome and from other organisms. Researchers should begin by analyzing the codon adaptation index (CAI) of the native Ppc1 sequence and redesigning the coding sequence to better match the codon usage frequency of highly expressed chloroplast genes such as rbcL or psbA . This process typically involves replacing rare codons with synonymous codons that are more frequently used in the chloroplast, while maintaining the amino acid sequence. Additionally, optimizing the GC content to match that of the chloroplast genome (approximately 35%) can further improve expression levels. Researchers should also consider removing any cryptic splice sites, internal shine-dalgarno sequences, or other motifs that might interfere with transcription or translation. The following table presents the preferred codons for several amino acids in the C. reinhardtii chloroplast that should be prioritized during Ppc1 codon optimization:
| Amino Acid | Preferred Codon(s) | Avoided Codon(s) |
|---|---|---|
| Alanine | GCU, GCA | GCG |
| Arginine | CGU, AGA | CGG, CGC |
| Leucine | UUA, CUU | CUG, CUC |
| Glycine | GGU, GGA | GGC, GGG |
| Serine | UCU, AGU | UCG |
| Proline | CCU, CCA | CCG |
CRISPR-Cas9 technology offers powerful approaches for both enhancing Ppc1 expression and studying its functional roles in C. reinhardtii. Recent advances in CRISPR protocols for C. reinhardtii have dramatically improved homology-directed knockin mutagenesis efficiency, enabling precise genetic modifications . For Ppc1 studies, CRISPR-Cas9 can be employed in several ways. First, researchers can create fusion proteins by inserting reporter tags (such as fluorescent proteins or epitope tags) at the C-terminus of the endogenous Ppc1 gene, enabling in vivo localization and interaction studies. Second, targeted promoter replacements can upregulate Ppc1 expression by substituting stronger promoters or by modifying regulatory elements to reduce sensitivity to carbon or nitrogen repression. Third, precise amino acid substitutions can be introduced to study structure-function relationships without disrupting the entire gene. When designing guide RNAs for Ppc1 targeting, researchers should select sequences with Doench activity scores >0.4 and minimal off-target potential . The homology arms for repair templates should be 500-1000bp in length to maximize integration efficiency. For successful transformation, preparing high-quality construct DNA (>300 ng/μL) and using autolysin treatment to remove the cell wall are critical steps . Screening transformants through a combination of PCR, phenotypic analysis, and sequencing ensures identification of cells with the desired genetic modifications.
Purifying recombinant Ppc1 from C. reinhardtii requires specialized approaches to address the unique challenges posed by this algal host. A multi-step purification protocol typically yields the best results, beginning with cell lysis under conditions that preserve enzyme activity. For C. reinhardtii, gentle lysis using glass beads or enzymatic methods in a buffer containing 50 mM HEPES (pH 7.5), 10 mM MgCl2, 1 mM EDTA, 5 mM DTT, and 10% glycerol helps maintain Ppc1 stability. Incorporating epitope tags (such as HA or His6) during recombinant expression facilitates affinity chromatography as the initial purification step . For His-tagged Ppc1, immobilized metal affinity chromatography (IMAC) using Ni-NTA resin under native conditions with imidazole gradients (20-250 mM) achieves good initial separation. Following affinity purification, ion exchange chromatography on Q-Sepharose columns at pH 8.0 with NaCl gradients (0-500 mM) helps remove contaminating proteins. Size exclusion chromatography serves as a polishing step to separate fully assembled tetrameric Ppc1 from unassembled subunits or aggregates. Throughout the purification process, the addition of 10% glycerol and 1 mM DTT to all buffers helps maintain enzyme stability. Purity assessment via SDS-PAGE typically shows a dominant band at approximately 109 kDa corresponding to the Ppc1 monomer, with purity levels exceeding 85% achievable through this protocol . Active enzyme fractions can be identified through activity assays measuring oxaloacetate formation from PEP and bicarbonate.
Accurate assessment of Ppc1 enzymatic activity requires carefully designed assays that account for the enzyme's biochemical properties and potential interfering factors in algal extracts. The most reliable approach couples the Ppc1 reaction to malate dehydrogenase (MDH), which converts oxaloacetate to malate while oxidizing NADH to NAD+. This spectrophotometric assay monitors NADH depletion at 340 nm, providing a continuous measurement of Ppc1 activity. The standard reaction mixture contains 50 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 10 mM NaHCO3, 2 mM PEP, 0.2 mM NADH, and 5 units of MDH. Temperature control is critical, with assays typically performed at 30°C to match optimal growth conditions for C. reinhardtii . For determining kinetic parameters, researchers should vary substrate concentrations (PEP: 0.05-5 mM; HCO3-: 0.1-20 mM) while measuring initial reaction velocities. Non-linear regression analysis using Michaelis-Menten or Hill equations then yields Km, Vmax, and potential cooperativity coefficients. When comparing different Ppc1 variants or conditions, specific activity (μmol min-1 mg-1 protein) provides a standardized metric. The following table summarizes key kinetic parameters typically determined for Ppc1 characterization:
| Kinetic Parameter | Typical Measurement Range | Experimental Conditions |
|---|---|---|
| Km(PEP) | 0.1-1.0 mM | pH 8.0, 30°C, 10 mM HCO3- |
| Km(HCO3-) | 0.5-5.0 mM | pH 8.0, 30°C, 2 mM PEP |
| Vmax | 1-10 μmol min-1 mg-1 | Saturating substrate conditions |
| pH optimum | pH 7.5-8.5 | Various buffer systems |
| Temperature optimum | 25-35°C | pH 8.0, saturating substrates |
Ppc1 mutagenesis studies benefit from recently developed CRISPR-Cas9 protocols that enable precise genetic modifications in C. reinhardtii. For site-directed mutagenesis of Ppc1, researchers should begin by designing guide RNAs targeting the region of interest, selecting those with Doench activity scores >0.4 to ensure efficient editing . The repair template should contain the desired mutation flanked by homology arms of 500-1000bp, with silent mutations in the PAM site to prevent re-cutting after successful editing. High-quality DNA preparation is essential, with researchers aiming for construct concentrations >300 ng/μL to maximize transformation efficiency . Prior to transformation, C. reinhardtii cells should be treated with autolysin to remove the cell wall, significantly improving DNA uptake . The transformation mix containing cells, CRISPR construct, and repair template can be delivered via electroporation or glass bead agitation methods. Following transformation, plating on selective media allows for identification of successfully transformed colonies. For screening, a tiered approach beginning with colony PCR followed by restriction digest analysis of PCR products can identify candidates with the desired mutations. Sanger sequencing confirmation of positive clones is essential to verify the precise mutation and rule out unintended modifications. For functional characterization of Ppc1 variants, phenotypic analyses examining growth rates under varying carbon and nitrogen conditions provide valuable insights into the physiological consequences of specific mutations .
The interaction between Ppc1 and nitrogen metabolism represents a crucial research area that can be explored through several complementary approaches. Transcriptomic analyses comparing wild-type and Ppc1 mutant strains under various nitrogen regimes (NH4+, NO3-, or N-deficient conditions) can reveal co-regulated gene networks that link carbon and nitrogen assimilation pathways . Metabolomic profiling using LC-MS/MS or NMR spectroscopy to quantify TCA cycle intermediates, amino acids, and nitrogen-containing compounds provides direct evidence of metabolic flux changes resulting from altered Ppc1 activity. Isotope labeling experiments utilizing 15N-labeled nitrogen sources combined with 13C-labeled carbon sources can track the incorporation of these elements into downstream metabolites, illuminating how Ppc1 activity influences nitrogen assimilation efficiency. Protein-protein interaction studies using techniques such as co-immunoprecipitation, yeast two-hybrid, or bimolecular fluorescence complementation can identify direct interactions between Ppc1 and nitrogen metabolism enzymes, potentially revealing regulatory complexes. Mathematical modeling approaches that integrate experimental data can simulate metabolic flux distributions under different conditions, generating testable hypotheses about how Ppc1 coordinates carbon provision for amino acid biosynthesis. For a system-level understanding, multi-omics approaches that combine transcriptomics, proteomics, and metabolomics data provide comprehensive insights into how Ppc1 functions within the broader metabolic network connecting carbon fixation and nitrogen assimilation in microalgae.
Engineered variants of Ppc1 hold significant potential for enhancing biofuel production in microalgae through strategic modifications of carbon flux distribution. Designing Ppc1 variants with reduced sensitivity to negative allosteric regulators (such as aspartate or malate) can increase anaplerotic carbon fixation even under elevated TCA cycle intermediate concentrations, directing more carbon toward fatty acid biosynthesis. Conversely, engineering Ppc1 with enhanced activity could divert carbon flux from photosynthate toward TCA cycle intermediates, potentially increasing the production of pyruvate and acetyl-CoA – key precursors for isoprenoid-based biofuels. Site-directed mutagenesis targeting the active site can create variants with altered substrate specificity or improved catalytic efficiency, optimizing carbon fixation under industrial cultivation conditions. Rational protein engineering focusing on the quaternary structure could yield more stable tetrameric forms of Ppc1 that maintain activity under the stress conditions often encountered in large-scale biofuel production systems. Expression of engineered Ppc1 variants under the control of inducible promoters would allow temporal control of carbon flux redistribution, enabling a growth phase focused on biomass accumulation followed by a production phase optimized for biofuel synthesis. The table below summarizes potential Ppc1 engineering strategies and their expected impacts on biofuel production:
Recombinant Ppc1 may exhibit low activity in experimental systems due to multiple factors related to protein expression, purification, and assay conditions. Improper protein folding represents a common challenge, particularly when expressing algal proteins in heterologous systems that lack appropriate chaperones. Co-expression with molecular chaperones such as the E. coli Spy protein has been shown to improve folding and activity of recombinant proteins in C. reinhardtii . Post-translational modifications present in native Ppc1 may be absent in recombinant versions, potentially affecting enzyme activity or stability. Additionally, the assembly of the quaternary structure (tetrameric form) essential for full Ppc1 activity may be compromised during expression or purification. Suboptimal buffer conditions during purification or activity assays can significantly impact enzyme functionality, with particular attention needed to pH (optimal range typically 7.5-8.5), metal ion concentrations (especially Mg2+), and reducing agent presence to maintain critical thiol groups in their reduced state. The absence of allosteric activators normally present in vivo, such as glucose-6-phosphate, may result in artificially low activity measurements in vitro. Finally, assay interference from components in crude extracts can mask true activity levels, necessitating careful control experiments and possibly more extensive purification before reliable activity measurements can be obtained.
Addressing protein folding challenges for recombinant Ppc1 requires a multi-faceted approach combining molecular design, expression optimization, and folding assistance strategies. Co-expression with molecular chaperones represents one of the most effective strategies, with the E. coli Spy chaperone showing particular promise for improving recombinant protein folding in the C. reinhardtii chloroplast . Researchers can introduce the Spy chaperone gene into expression vectors under the control of strong promoters like psaA to ensure adequate chaperone levels during Ppc1 expression . Optimizing growth temperature is equally critical, with lower temperatures (20-25°C) during the induction phase generally slowing protein synthesis and allowing more time for proper folding. Expression vector design should include appropriate targeting sequences to direct the protein to cellular compartments where folding machinery is abundant. For chloroplast expression, maintaining ionic conditions that mimic the stroma environment (relatively high Mg2+ and K+ concentrations) helps stabilize folding intermediates. Adding chemical chaperones such as glycerol (5-10%) or low concentrations of urea (0.1-0.5 M) to the growth medium can also improve folding outcomes by stabilizing partially folded intermediates. For proteins that contain disulfide bonds, ensuring an appropriate redox environment through the addition of glutathione mixtures or thioredoxin can facilitate correct disulfide formation. When purifying Ppc1, gradient elution techniques and mild solubilization conditions help maintain the native conformation and quaternary structure essential for enzymatic activity.
Low transformation efficiency represents a significant challenge when introducing Ppc1 expression constructs into C. reinhardtii, but several strategies can substantially improve outcomes. Preparation of high-quality, clean DNA is paramount, with researchers aiming for construct concentrations exceeding 300 ng/μL for optimal results . The use of autolysin treatment to remove the cell wall before transformation dramatically increases DNA uptake efficiency, with freshly prepared autolysin typically yielding better results than stored preparations . Electroporation parameters should be optimized specifically for Ppc1 constructs, with field strengths between 1500-2000 V/cm typically providing a good balance between cell viability and DNA uptake. For chloroplast transformations, constructs should include homologous flanking sequences (1-2 kb) that target integration to neutral sites in the chloroplast genome to avoid disrupting essential genes. Using selectable markers appropriate for either nuclear or chloroplast transformation (such as spectinomycin resistance for chloroplast) enables efficient selection of transformants . When targeting nuclear integration, smaller construct sizes generally transform more efficiently, suggesting that minimizing unnecessary vector components can improve success rates. Additionally, the growth phase of recipient cells significantly affects transformation outcomes, with mid-log phase cultures typically showing optimal competence. After transformation, a recovery period in non-selective liquid medium for 24-48 hours before plating on selective media often improves colony recovery by allowing cells to express resistance markers before exposure to selection pressure.
Emerging technologies offer exciting possibilities for deepening our understanding of Ppc1 function and regulation in C. reinhardtii. Single-cell multi-omics approaches combining transcriptomics, proteomics, and metabolomics at the individual cell level could reveal previously undetected heterogeneity in Ppc1 expression and activity within algal populations. These technologies would provide insights into how microenvironmental variations influence Ppc1 regulation at unprecedented resolution. Cryo-electron microscopy (cryo-EM) techniques are rapidly advancing to achieve near-atomic resolution of complex protein structures, potentially allowing visualization of Ppc1 in its native tetrameric state and in complex with regulatory partners. This structural information would enable rational protein engineering approaches to modify Ppc1 function for specific applications. CRISPR-based epigenome editing tools adapted for microalgae could help unravel the chromatin-level regulatory mechanisms controlling Ppc1 expression in response to environmental stimuli . In vivo biosensors that report on Ppc1 activity in real-time through fluorescent or luminescent outputs would transform our ability to monitor dynamic changes in enzyme function under varying conditions. Microfluidic cultivation systems coupled with real-time imaging and metabolite analysis would allow precise control of the microenvironment while monitoring cellular responses, ideally suited for studying Ppc1's role in carbon/nitrogen balance under fluctuating conditions. Synthetic biology approaches including genetic circuit design could enable the construction of feedback-regulated Ppc1 expression systems that respond to metabolic demands, potentially optimizing carbon flux for biotechnological applications.
Advanced engineering of Ppc1 opens avenues for diverse biotechnological applications that extend beyond traditional biofuel production. Designed Ppc1 variants with enhanced carbon fixation capabilities could serve as foundational components for synthetic carbon-fixing pathways in non-photosynthetic industrial microorganisms, potentially enabling direct utilization of CO2 as a feedstock for chemical production. Engineering Ppc1 to function efficiently under the high temperatures typical of industrial fermentation could allow integration of enhanced carbon fixation with established bioprocessing platforms. Ppc1 variants optimized for activity in high-salt environments could facilitate development of halophilic algal production systems that utilize non-potable water resources, expanding cultivation possibilities to coastal and desert regions. Immobilization of engineered Ppc1 on biocatalytic surfaces could create bioinorganic carbon capture systems that function outside living cells, potentially offering new approaches for environmental CO2 remediation. Engineered Ppc1 pathways in microalgae could enhance production of high-value compounds through improved provision of carbon skeletons for specialized metabolite biosynthesis, including pharmaceuticals, nutraceuticals, and specialty chemicals. The strategic coupling of Ppc1 engineering with nitrogen metabolism optimization could yield strains with superior capabilities for environmental bioremediation, efficiently removing both carbon and nitrogen pollutants from wastewater streams. These diverse applications highlight the potential of Ppc1 as a versatile biotechnological tool whose utility extends far beyond its native role in algal metabolism.